-
EP4216940
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4216940
| EP4216940 - PYRIDO[4,3-B]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 30.06.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 02.04.2022 | Most recent event Tooltip | 01.10.2024 | Change - representative | Applicant(s) | For all designated states Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Waltham, MA 02453 / US | [2023/31] | Inventor(s) | 01 /
FADER, Lee Montréal, Québec H4S 2A1 / CA | 02 /
BURCH, Jason Montréal, Québec H4S 2A1 / CA | 03 /
ST-ONGE, Miguel Montréal, Québec H4S 2A1 / CA | 04 /
DORICH, Stéphane Montréal, Québec H4S 2A1 / CA | [2023/31] | Representative(s) | Schlich 9 St Catherine's Road Littlehampton West Sussex BN17 5HS / GB | [N/P] |
| Former [2023/31] | Schlich, George Schlich 9 St Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | Application number, filing date | 21873398.8 | 23.09.2021 | [2023/31] | WO2021US51670 | Priority number, date | US202063082695P | 24.09.2020 Original published format: US 202063082695 P | [2023/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022066851 | Date: | 31.03.2022 | Language: | EN | [2022/13] | Type: | A1 Application with search report | No.: | EP4216940 | Date: | 02.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.03.2022 takes the place of the publication of the European patent application. | [2023/31] | Search report(s) | International search report - published on: | US | 31.03.2022 | Classification | IPC: | A61K31/138, A61K31/437, A61K31/4545 | [2023/31] | CPC: |
C07D471/04 (EP,US);
A61P37/02 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/31] | Title | German: | PYRIDO[4,3-B INDOLDERIVATE UND IHRE VERWENDUNG ALS ARZNEIMITTEL | [2023/31] | English: | PYRIDO[4,3-B]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | [2023/31] | French: | DÉRIVÉS DE PYRIDO[4,3-B]INDOLE ET LEUR UTILISATION COMME PRODUITS PHARMACEUTIQUES | [2023/31] | Entry into regional phase | 17.03.2023 | National basic fee paid | 17.03.2023 | Search fee paid | 17.03.2023 | Designation fee(s) paid | 17.03.2023 | Examination fee paid | Examination procedure | 17.03.2023 | Examination requested [2023/31] | 31.10.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 29.09.2023 | Renewal fee patent year 03 | 19.09.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2013190331 (JAIN RAJENDRA PARASMAL [IN], et al) [A] 1-3 and 21 * entire-document *; | [A]WO2017216279 (HOFFMANN LA ROCHE [CH], et al) [A] 1-3 and 21* entire document *; | [X]WO2019153002 (LAMA LODOE [US], et al) [X] 1-3 and 21 * entire document especially para [009]; [0104] * | [A] - PubChem, (20090530), Database accession no. 4250 7259 [A] 1-3 and 21 * formula * |